Review article: Immediate-release proton-pump inhibitor therapy - Potential advantages

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 22, Issue 3, 2005, Pages 25-30

  Howden, C W ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Division of Gastroenterology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; BICARBONATE; OMEPRAZOLE; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

AREA UNDER THE CURVE; CLINICAL TRIAL; DELAYED DRUG RELEASE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; ENTERIC COATED TABLET; GASTROESOPHAGEAL REFLUX; HUMAN; IMMEDIATE RELEASE FORMULATION; PRIORITY JOURNAL; REVIEW; STEADY STATE; STOMACH ACID; STOMACH PH;

EID: 28944438410     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02709.x     Document Type: Review

References (19)

1. Freston JW, Chiu YL, Mulford DJ, Ballard ED. Comparative pharmacokinetics and safety of lansoprazole oral capsules and orally disintegrating tablets in healthy subjects. Aliment Pharmacol Ther 2003; 17: 361-7.
2. Howden CW, Meredith PA, Forrest JA, Reid JL. Oral pharmacokinetics of omeprazole. Eur J Clin Pharmacol 1984; 26: 641-3.
3. Howden CW, Forrest JA, Meredith PA, Reid JL. Antisecretory effect and oral pharmacokinetics following low dose omeprazole in man. Br J Clin Pharmacol 1985; 20: 137-9.
4. McQuaid KR, Laine L. Early heartburn relief with proton pump inhibitors: a systematic review and meta-analysis of clinical trials. Clin Gastroenterol Hepatol 2005; 3: 553-63.
5. Sharma VK, Vasudeva R, Howden CW. The effects on intragastric acidity of per-gastrostomy administration of an alkaline suspension of omeprazole. Aliment Pharmacol Ther 1999; 13: 1091-5.
6. Sharma VK, Peyton B, Spears T, Raufman JP, Howden CW. Oral pharmacokinetics of omeprazole and lansoprazole after single and repeated doses as intact capsules or as suspensions in sodium bicarbonate. Aliment Pharmacol Ther 2000; 14: 887-92.
7. Song JC, Quercia RA, Fan C, Tsikouris J, White CM. Pharmacokinetic comparison of omeprazole capsules and a simplified omeprazole suspension. Am J Health Syst Pharm 2001; 58: 689-94.
8. Hepburn B, Goldlust B. Comparative effects of an omeprazole antacid complex-immediate release (OAC-IR) and omeprazole delayed-release (OME-DR) on omeprazole pharmacokinetics and gastric pH in healthy subjects Gastroenterology 2003; 124: A228 (Abstract).
9. Package insert: Immediate-release omeprazole [(IR-OME) Zegerid® powder for oral suspension. Santarus Inc., San Diego, CA, USA].
10. Data on File. San Diego, CA, USA: Santarus, Inc., 2005.
11. Goldlust B, Hepburn B, Hardiman Y. Nighttime dosing of omeprazole immediate-release oral suspension rapidly decreases nocturnal gastric acidity Am J Gastroenterol 2004; 99: S39 (Abstract 116).
12. Feurle GE. The action of antacids on serum gastrin concentrations in man. Klin Wochenschr 1977; 55: 1039-42.
13. Tuynman HA, Festen HP, Rohss K, Meuwissen SG. Lack of effect of antacids on plasma concentrations of omeprazole given as enteric-coated granules. Br J Clin Pharmacol 1987; 24: 833-5.
14. Howden CW, Reid JL. The effect of antacids and metoclopramide on omeprazole absorption and disposition. Br J Clin Pharmacol 1988; 25: 779-81.
15. Yasuda S, Higashi S, Murakami M, Tomono Y, Kawaguchi M. Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers. Int J Clin Pharmacol Ther 1999; 37: 249-53.
16. Delhotal-Landes B, Cournot A, Vermerie N, et al. The effect of food and antacids on lansoprazole absorption and disposition. Eur J Drug Metab Pharmacokinet 1991; 3: 315-20.
17. Peters MN, Feldman M, Walsh JH, Richardson CT. Effect of gastric alkalinization on serum gastrin concentrations in humans. Gastroenterology 1983; 85: 35-9.
18. Lee TJ, Fennerty MB, Howden CW. Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease? Aliment Pharmacol Ther 2004; 20: 1241-51.
19. Castell D. Review of immediate-release omeprazole for the treatment of gastric and related disorders. Expert Opin Pharmacother 2005 (in press).